Financial Information

Pharmaceutical Product Development, Inc.

NASD: (PPDI)
Sector: Healthcare
Industry: Biotechnology & Drugs
BRIEF: For the six months ended 30 June 2007, Pharmaceutical Product Development, Inc.'s revenues increased 12 percent to $682.2 million. Net income increased 8 percent to $84.6 million. Revenues reflect an increase in sales from development division and higher sales from reimbursed out-of-pocket sales. Net income was partially offset by an increase in research & development expenses, higher selling, general & administrative expenses and increased depreciation expenses.

OFFICERS: Ernest Mario, Chairman of the Board; Fredric Eshelman, Vice Chairman of the Board, Chief Executive Officer; Daniel Darazsdi, Chief Financial Officer; William Sharbaugh, Chief Operating Officer; Paul Covington, Executive Vice President - Development.

TRANSFER AGENT: American Stock Transfer Trust Company. Company incorporated in N.C. Direct inquiries to: Director of Investor Relations.

Pharmaceutical Product Development, Inc.
929 North Front Street
Wilmington, NC 28401
Phone: +910 558 7585
Fax: +910 558 7056

Sector Name: Healthcare
Industry Name: Biotechnology & Drugs
Complete Financials: 30 Jun 2007

Latest Earnings Release & 10-Q Date Filed Format Size  
Fourth Quarter Financial Results HTML file N/A  
Form 10-Q Nov 3, 2009 HTML file  PDF file 571.3 KB Add to Briefcase
 
Latest Annual Report & 10-K Date Filed Format Size  
Form 10-K Feb 26, 2010 HTML file  PDF file 2.4 MB Add to Briefcase
 
Add to Briefcase = add file to Briefcase
Ticker PPDI
Exchange NASDAQ
Price $22.06
Change - 0.07
Volume 1,124,400
3/15/2010 - 3:59 PM ET

Annual Report